Back to Search Start Over

Supramolecular Motion Enables Chondrogenic Bioactivity of a Cyclic Peptide Mimetic of Transforming Growth Factor-β1.

Authors :
Yuan SC
Álvarez Z
Lee SR
Pavlović RZ
Yuan C
Singer E
Weigand SJ
Palmer LC
Stupp SI
Source :
Journal of the American Chemical Society [J Am Chem Soc] 2024 Aug 07; Vol. 146 (31), pp. 21555-21567. Date of Electronic Publication: 2024 Jul 25.
Publication Year :
2024

Abstract

Transforming growth factor (TGF)-β1 is a multifunctional protein that is essential in many cellular processes that include fibrosis, inflammation, chondrogenesis, and cartilage repair. In particular, cartilage repair is important to avoid physical disability since this tissue does not have the inherent capacity to regenerate beyond full development. We report here on supramolecular coassemblies of two peptide amphiphile molecules, one containing a TGF-β1 mimetic peptide, and another which is one of two constitutional isomers lacking bioactivity. Using human articular chondrocytes, we investigated the bioactivity of the supramolecular copolymers of each isomer displaying either the previously reported linear form of the mimetic peptide or a novel cyclic analogue. Based on fluorescence depolarization and <superscript>1</superscript> H NMR spin-lattice relaxation times, we found that coassemblies containing the cyclic compound and the most dynamic isomer exhibited the highest intracellular TGF-β1 signaling and gene expression of cartilage extracellular matrix components. We conclude that control of supramolecular motion is emerging as an important factor in the binding of synthetic molecules to receptors that can be tuned through chemical structure.

Details

Language :
English
ISSN :
1520-5126
Volume :
146
Issue :
31
Database :
MEDLINE
Journal :
Journal of the American Chemical Society
Publication Type :
Academic Journal
Accession number :
39054767
Full Text :
https://doi.org/10.1021/jacs.4c05170